Literature DB >> 26667738

VALIDATION AND COMPARISON OF EQ-5D-3L AND SF-6D INSTRUMENTS IN A SPANISH PARKINSON´S DISEASE POPULATION SAMPLE.

Miguel Ángel Garcia-Gordillo1, B Del Pozo-Cruz2, J C Adsuar3, J M Cordero-Ferrera4, J M Abellan-Perpiñan5, F I Sanchez-Martinez6.   

Abstract

INTRODUCTION: generic, preference-based Health- Related Quality of Life instruments are receiving growing attention in health-care decision-making process. In spite of this, to our knowledge, EQ-5D and SF-6D have never been compared in a Parkinson´s disease population sample.
OBJECTIVE: the aim of this paper was to assess the psychometric properties of both instruments in a Spanish PD population sample.
METHODS: a total sample of 133 patients were interviewed using EQ-5D-3L and SF-6D. The validity, level of agreement and sensitivity of both instruments were computed and then compared. The Spanish tariff has been used in both instruments.
RESULTS: utilities of EQ-5D-3L and SF-6D have shown a strong correlation (r >0.50 and p<0.001) with the summary score of the PDQ-8 and the EQ-VAS score. Significant differences were observed in the stages III-IV of the Hoehn &amp; Yahr stage. SF-6D had 51% higher efficiency than EQ-5D at detecting differences in symptoms severity. DISCUSSION: both EQ-5D-3L and SF-6D seem to be adequate generic Health-Related Quality of Life measures in terms of validity and sensitivity.
CONCLUSION: EQ-5D-3L presents greater ceiling and floor effects than the SF-6D instrument in this sample. Besides, the instrument SF-6D was better at detecting changes in symptoms severity compared with EQ-5D-3L. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26667738     DOI: 10.3305/nh.2015.32.6.9765

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  6 in total

1.  Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.

Authors:  Carmen Selva-Sevilla; Paula Ferrara; Manuel Gerónimo-Pardo
Journal:  Eur J Health Econ       Date:  2020-02-17

2.  Analysis of the Impact of the Confinement Resulting from COVID-19 on the Lifestyle and Psychological Wellbeing of Spanish Pregnant Women: An Internet-Based Cross-Sectional Survey.

Authors:  Gemma Biviá-Roig; Valentina Lucia La Rosa; María Gómez-Tébar; Lola Serrano-Raya; Juan José Amer-Cuenca; Salvatore Caruso; Elena Commodari; Antonio Barrasa-Shaw; Juan Francisco Lisón
Journal:  Int J Environ Res Public Health       Date:  2020-08-15       Impact factor: 3.390

3.  Comparing the EQ-5D-3 L and EQ-5D-5 L: studying measurement and scores in Indonesian type 2 diabetes mellitus patients.

Authors:  Bustanul Arifin; Fredrick Dermawan Purba; Hendra Herman; John M F Adam; Jarir Atthobari; Catharina C M Schuiling-Veninga; Paul F M Krabbe; Maarten J Postma
Journal:  Health Qual Life Outcomes       Date:  2020-02-07       Impact factor: 3.186

4.  A Feasibility Study for Implementation "Health Arcade": A Study Protocol for Prototype of Multidomain Intervention Based on Gamification Technologies in Acutely Hospitalized Older Patients.

Authors:  César Cuevas-Lara; Mikel Izquierdo; Fabiola Zambom-Ferraresi; Mikel L Sáez de Asteasu; Itxaso Marín-Epelde; Chenhui Chenhuichen; Fabricio Zambom-Ferraresi; Robinson Ramírez-Vélez; Antonio García-Hermoso; Álvaro Casas-Herrero; Amaya Capón-Sáez; Lucia Lozano-Vicario; Irene Criado-Martín; Marina Sánchez-Latorre; Cristina Antoñanzas-Valencia; Nicolás Martínez-Velilla
Journal:  Int J Environ Res Public Health       Date:  2020-11-01       Impact factor: 3.390

5.  Quality of Life and Depressive Symptoms Among Peruvian University Students During the COVID-19 Pandemic.

Authors:  Joel Figueroa-Quiñones; Julio Cjuno; Daniel Machay-Pak; Miguel Ipanaqué-Zapata
Journal:  Front Psychol       Date:  2022-02-23

6.  Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson's Disease: A Swedish Register-Based Study in 1823 Observations.

Authors:  Jenny M Norlin; Klas Kellerborg; Per Odin
Journal:  Pharmacoeconomics       Date:  2021-07-07       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.